Interim CEO Anders Lonning-Skovgaard - Executive Vice President, CFO Kristine Husted Munk - Senior Director, Investor Relations Simone Dyrby Helvind - Senior Manager, Investor Relations Webcast For ...
Pritelivir Phase 2 results supported FDA Breakthrough Therapy Designation and informed the pivotal study design, which recently culminated in positive Phase 3 topline results Phase 1 results for ...
The Living Brain Project (LBP) is a collaborative research initiative led by the Icahn School of Medicine at Mount Sinai. Its mission is to generate, analyze, and openly share the world’s first ...
J-Star (through its YMA subsidiary) has manufactured racquets for several leading global brands and recently launched its first company owned pickleball paddle, Horizon. Visit ymapaddles.com for more ...
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
During the past few months, Replimune has been working to address agency feedback. Additional information, data and analyses were included in the resubmission which will be part of the BLA review. The ...
The tender offer will expire at 5:00 p.m. ET on Tuesday, November 18, 2025, unless extended or earlier terminated. The full terms, conditions and other details of the tender offer are set forth in the ...
This follow-on investment builds on Angelini Ventures' co-lead participation in CoMind's 2023 Series A funding round of $27 million alongside Octopus Ventures and underscores Angelini Ventures' ...
Ensign invites current and prospective investors to tune into a live webcast to be held the following day, Tuesday, November 4, 2025, at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time), during which ...
RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital ...
RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2025 financial results on ...
Jefferies, Leerink Partners, Morgan Stanley and Cantor are acting as joint book-running managers for the proposed offering.
Details: This summit organized by Oppenheimer & Co. in partnership with the University of Miami Sylvester Cancer Center, focuses on oncology advancements, offering Medicenna a platform to discuss its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback